Publicaciones en las que colabora con Susana Roselló (10)

2019

  1. Assessing molecular subtypes of gastric cancer: Microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications

    ESMO Open, Vol. 4, Núm. 3

  2. Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens

    Histopathology, Vol. 75, Núm. 4, pp. 517-525

  3. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

    Modern Pathology, Vol. 32, Núm. 2, pp. 306-313

2018

  1. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2

2016

  1. Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology

    Oncotarget, Vol. 7, Núm. 16, pp. 22543-22555

  2. Epigenetic changes in localized gastric cancer: The role of RUNX3 in tumor progression and the immune microenvironment

    Oncotarget, Vol. 7, Núm. 39, pp. 63424-63436

2015

  1. Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer

    Oncotarget, Vol. 6, Núm. 29, pp. 26935-26945

2011

  1. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer

    Cancer, Vol. 117, Núm. 14, pp. 3118-3125

2010

  1. The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment

    Clinical and Translational Oncology, Vol. 12, Núm. 5, pp. 339-345

2008

  1. Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: Perioperative management of rectal cancer

    Annals of Oncology